COPD, Bronchiectasis and Asthma Longitudinal Trends

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS1000000925
• Study ID:
  1000000925
• Official title and acronym:
  COPD, Bronchiectasis and Asthma Longitudinal Trends
• DARWIN EU® study:
  No
• Study countries:
  France

  Germany

  Japan

  United States
• Study description:
  This study aims to describe recent trends in exacerbation rates among patients with COPD, asthma, and bronchiectasis, and to characterize patient demographics, disease characteristics, and clinical management practices across the included countries.
• Study status:
  Planned

Research institutions and networks

Institutions

Chiesi Farmaceutici

Global Database Studies, IQVIA

Czechia

Finland

Germany

Slovakia

Spain

Study timelines

Date when funding contract was signed

Actual:08/10/2025

Study start date

Planned:10/02/2026

Data analysis start date

Planned:02/03/2026

Date of final study report

Planned:29/05/2026

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Chiesi Farmaceutici SpA

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable